High Pointe Capital Management’s AstraZeneca AZN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,690	Closed	-$1.5M	–	87
2020 Q3	$1.5M	Sell	13,690 -200	-1%	-$22.2K	1.82%	19
2020 Q2	$1.47M	Sell	13,890 -1,110	-7%	-$115K	1.93%	19
2020 Q1	$1.34M	Buy	15,000 +350	+2%	+$32.9K	1.91%	20
2019 Q4	$1.46M	Hold	14,650	–	–	1.73%	24
2019 Q3	$1.31M	Sell	14,650 -170	-1%	-$14.7K	1.79%	19
2019 Q2	$1.22M	Hold	14,820	–	–	1.71%	20
2019 Q1	$1.2M	Sell	14,820 -1,070	-7%	-$84.3K	1.64%	22
2018 Q4	$1.21M	Buy	15,890 +490	+3%	+$38.3K	1.99%	13
2018 Q3	$1.22M	Sell	15,400 -620	-4%	-$46.9K	1.64%	27
2018 Q2	$1.13M	Buy	16,020 +6,850	+75%	+$493K	1.6%	27
2018 Q1	$641K	Buy	9,170 +640	+8%	+$44.3K	0.88%	48
2017 Q4	$592K	Hold	8,530	–	–	0.81%	46
2017 Q3	$578K	Buy	8,530 +710	+9%	+$44.9K	0.85%	46
2017 Q2	$533K	Buy	7,820 +1,935	+33%	+$126K	0.83%	50
2017 Q1	$367K	Hold	5,885	–	–	0.58%	55
2016 Q4	$322K	Sell	5,885 -245	-4%	-$13.9K	0.53%	55
2016 Q3	$403K	Hold	6,130	–	–	0.72%	49
2016 Q2	$370K	Buy	6,130 +1,980	+48%	+$115K	0.56%	57
2016 Q1	$234K	Buy	+4,150	New	+$249K	0.34%	63